Probably not – although, various efforts are being employed by the Canadian government to tackle the counterfeit products industry and protect the Canadian consumer.
Considering the Combating Counterfeit Products Act: Who Should Ease the Burden of an Overburdened System?
Bill C-8 (the Combating Counterfeit Products Act, previously known as Bill C-56) passed third reading in the House of Commons on October 2, 2014, and is now before the Senate for further review. The Bill proposes a number of legislative changes to the Canadian IP regime. One of its main objectives is to create […]
On January 21, the WHO 130th WHO Executive Board (EB) adopted a resolution for agenda item 6.13 "substandard/spurious/falsely-labelled/falsified/counterfeit medical products” [SFFC]. The resolution is intended to address the growing prevalence of and the health risks associated with “deliberately and fraudulently mislabelled” pharmaceuticals.